Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s12876-018-0857-0.pdf
Reference23 articles.
1. Moore CM, Van Thiel DH. Cirrhotic ascites review: pathophysiology, diagnosis and management. World J Hepatol. 2013;5:251–63.
2. Yu C, SharmaN SS. Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis. ExpClin Transplant. 2013;11:3–11.
3. Gordon FD. Ascites. Clin Liver Dis. 2012;16:285–99.
4. Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis, 2012. Hepatology. 2013;57:1651–3.
5. Leiva JG, Salgado JM, Estradas J, Torre A, Uribe M. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents. Ann Hepatol. 2007;6:214–21.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hyponatremia in the Context of Liver Disease;Advances in Kidney Disease and Health;2024-03
2. Konsensusempfehlungen zur Diagnose und Therapie der Hyponatriämie der Österreichischen Gesellschaft für Nephrologie 2024;Wiener klinische Wochenschrift;2024-02
3. Efficacy and safety of tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Gastroenterology & Hepatology;2023-10-03
4. Evidence-based hyponatremia management in liver disease;Clinical and Molecular Hepatology;2023-10-01
5. Ribosomal s6 kinase (RSK) is a mediator of aquaporin 2 S256 phosphorylation and membrane accumulation after EGFR inhibition with erlotinib;2022-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3